NASDAQ:AMGN

Amgen Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy AMGN

*Your capital is at risk

$338.22

+9.96 (+3.03%)

At Close: Jun 03, 2026

Amgen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 39.41. In total, the insiders bought 565.06M and sold 163.08K AMGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	39.41
● Buy	565.06M shares
● Sell	163.08K shares
46% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence May 05, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 39.41. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 19, 2026 Buy	Common Stock A-Award	Kullman Ellen Jamison Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Miles Amy E Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Jacks Tyler Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Klotman Mary E. Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Ishrak Omar Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Drake Michael V Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Druker Brian Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Eckert Robert Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Garland Greg C. Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Holley Charles M Director	Director	665 Value: $219.9K
May 19, 2026 Buy	Common Stock A-Award	Austin Wanda M Director	Director	665 Value: $219.9K
May 07, 2026 Sell	Common Stock F-InKind	Busch Matthew C. Vp, Finance & Cao	Officer	41 Value: $13.6K
May 07, 2026 Sell	Common Stock F-InKind	Grygiel Nancy A. SVP & Cco	Officer	88 Value: $29.1K
May 07, 2026 Sell	Common Stock F-InKind	Khosla Rachna SVP, Business Development	Officer	93 Value: $30.8K
May 07, 2026 Sell	Common Stock F-InKind	Miller Derek SVP, Human Resources	Officer	151 Value: $50.0K
May 07, 2026 Sell	Common Stock F-InKind	Reese David M EVP & Chief Technology Officer	Officer	556 Value: $184.1K
May 07, 2026 Sell	Common Stock F-InKind	Santos Esteban EVP, Operations	Officer	522 Value: $172.8K
May 07, 2026 Sell	Common Stock F-InKind	Graham Jonathan P EVP & Gen. Counsel & Sec.	Officer	499 Value: $165.2K
May 07, 2026 Sell	Common Stock F-InKind	Griffith Peter H. EVP & CFO	C-Suite Officer	556 Value: $184.1K
May 07, 2026 Sell	Common Stock F-InKind	Bradner James E. EVP, Research And Development	Officer	446 Value: $147.7K
May 07, 2026 Sell	Common Stock F-InKind	Bradway Robert A Chairman, CEO And President	CEO / President	2 079 Value: $688.4K
May 07, 2026 Sell	Common Stock F-InKind	Gordon Murdo EVP, Global Commercial Ops	Officer	615 Value: $203.6K
May 06, 2026 Sell	Common Stock F-InKind	Santos Esteban EVP, Operations	Officer	427 Value: $140.7K
May 06, 2026 Sell	Common Stock F-InKind	Khosla Rachna SVP, Business Development	Officer	79 Value: $26.0K
May 06, 2026 Sell	Common Stock F-InKind	Grygiel Nancy A. SVP & Cco	Officer	76 Value: $25.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AMGEN INC.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus...

Read Full Profile Here